Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 12, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Cantor Fitzgerald Global Healthcare Conference, which takes place September 2

Related Keywords

United States ,New York ,Mont Saint Guibert ,Waals Gewest ,Belgium ,David Demartino ,Olivier Taelman ,Company Investor Relations ,Nasdaq ,Cantor Fitzgerald Global ,Obstructive Sleep Apnea ,Cantor Fitzgerald Global Healthcare Conference ,Chief Executive Officer ,Investor Relations ,Investor Presentation ,Shareholder Information ,Euronext Brussels ,Complete Concentric Collapse ,Chief Strategy ,Cantor Fitzgerald ,Medical Technology Company ,Nyxoah Sa ,Ommercialization ,The Company ,